Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1968 (LINC01968) is a human long non-coding RNA (lncRNA), specifically a long intergenic non-protein coding RNA, meaning it is transcribed from genomic regions located between protein-coding genes and does not itself encode a protein[1][7]. Like other lincRNAs, LINC01968 is believed to function primarily as a regulatory RNA involved in controlling gene expression at various levels, including chromatin organization, transcriptional, and post-transcriptional regulation[5][7]. While dysregulation of lncRNAs as a class is associated with diseases such as cancer, cardiovascular diseases, and neurological disorders, there is no direct evidence that LINC01968 is a therapeutic target, nor are any drugs known to interact with it[1][7]. There is also no firm evidence that LINC01968 is currently used as a biomarker for patient selection or monitoring. Functional characterization of individual lincRNAs is ongoing, and their precise disease and regulatory roles, including those of LINC01968, are still being elucidated[3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1968 (LINC01968).